Workshop
CLIN
1. Pancreatic Cysts Across the CFTR Disease Spectrum: Prevalence, Predictors, and Clinical Implications – Presented by Daniel Dong
2. Colon Cancer Screening in Cystic Fibrosis: Lessons Learned from a Multiphase Quality Improvement Project – Presented by Abigail Braun
3. PROBE-CF: Profiling Biomarkers of the Esophagus in Patients with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor – Presented by Racha Khalaf
4. Pancreatic Cystosis or IPMN? Characterizing Cystic Pancreatic Lesions in Cystic Fibrosis – Presented by Carlie Aurubin
5. Body Composition and Clinical Implications in Adults With CF: Baseline Results of the STRONG-CF Study – Presented by Adam Stein
Molly Bozic, MD
Riley Hospital for Children
Jason Rocha, MD
University of Texas Health at San Antonio
Daniel Dong
Massachusetts General Hospital
Abigail Braun, MD
The Ohio State University Wexner Medical Center
Racha Khalaf
University of South Florida
Carlie A. Aurubin, MD, PhD
Mayo Clinic
Adam C. Stein
Northwestern Medicine